Palatal drug delivery
US10806675B2 · kind B2 · utility
Inventor
Key dates
| Filing date | Aug 30, 2017 |
| Grant date | Oct 20, 2020 |
| Priority date | — |
| Expiry date | Jun 24, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61J7/0092
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
Drug delivery devices and systems are disclosed that allow precise, controlled drug delivery via the oral palatal mucosa. The drug delivery devices can be easily used by a patient or other user, and reduce the likelihood of (or in some cases eliminate) dilution of the drug by saliva and fluids and inadvertent swallowing or unplanned uptake of the drug by the patient. The drug delivery devices include a body shaped to conform to a user's palate, and cavities in a palate-facing surface of the body that are configured to receive a drug in liquid form.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.